Amalgamated Financial’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Amalgamated Financial’s Portfolio FMTX Stock Details FMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$38K	Buy	+4,107	New	+$43.7K	﹤0.01%	2543

Other funds holding FMTX

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Amalgamated Financial's FMTX Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q1 2022: 4,107 shares worth $38K. The stake represents ﹤0.01% of the portfolio and ranks #2543 among its holdings.

98 funds tracked by Wall St. Rank hold FMTX as of Q1 2022.

Amalgamated Financial held 4,107 shares of Forma Therapeutics Holdings, Inc. Common Stock worth $38K as of Q1 2022.
Forma Therapeutics Holdings, Inc. Common Stock was a new Amalgamated Financial position in Q1 2022.
Forma Therapeutics Holdings, Inc. Common Stock made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2543 holding.
98 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.